Shweta Agarwal

DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma

Nathaniel Weygant, Dongfeng Qu, Randal May et al. · Oncotarget · 2014 · 111 citations · Full text

Rcc Dataset, Pathology, Cancer Biology +19

Effect of interference from hemolysis, icterus and lipemia on routine pediatric clinical chemistry assays

Shweta Agarwal, Germán Vargas, C. G. Nordström et al. · Clinica Chimica Acta · 2014 · 55 citations

Pediatric Hematology, Medicine, Bioanalysis +7

FaceTime validation study: Low‐cost streaming video for cytology adequacy assessment

Shweta Agarwal, Lichao Zhao, Roy Zhang et al. · Cancer Cytopathology · 2015 · 28 citations · Full text

Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies

Nicole A. Cipriani, Shweta Agarwal, Dora Dias‐Santagata et al. · Thyroid · 2017 · 28 citations

Myoepithelial Carcinoma Ex-Pleomorphic Adenoma: A Rare Pathology Misdiagnosed as Pleomorphic Adenoma; With a Novel TERT Promoter Mutation and High PD-L1 Expression

Christopher Cormier, Shweta Agarwal · Head and Neck Pathology · 2021 · 25 citations · Full text

Tumor Biology, Tumoral Pathology, High Pd-l1 Expression +8